Literature DB >> 18504433

Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma.

Y-L Liao1, Y-M Sun, G-Y Chau, Y-P Chau, T-C Lai, J-L Wang, J-T Horng, M Hsiao, A-P Tsou.   

Abstract

A comprehensive microarray analysis of hepatocellular carcinoma (HCC) revealed distinct synexpression patterns during intrahepatic metastasis. Recent evidence has demonstrated that synexpression group member genes are likely to be regulated by master control gene(s). Here we investigate the functions and gene regulation of the transcription factor SOX4 in intrahepatic metastatic HCC. SOX4 is important in tumor metastasis as RNAi knockdown reduces tumor cell migration, invasion, in vivo tumorigenesis and metastasis. A multifaceted approach integrating gene profiling, binding site computation and empirical verification by chromatin immunoprecipitation and gene ablation refined the consensus SOX4 binding motif and identified 32 binding loci in 31 genes with high confidence. RNAi knockdown of two SOX4 target genes, neuropilin 1 and semaphorin 3C, drastically reduced cell migration activity in HCC cell lines suggesting that SOX4 exerts some of its action via regulation of these two downstream targets. The discovery of 31 previously unidentified targets expands our knowledge of how SOX4 modulates HCC progression and implies a range of novel SOX4 functions. This integrated approach sets a paradigm whereby a subset of member genes from a synexpression group can be regulated by one master control gene and this is exemplified by SOX4 and advanced HCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504433     DOI: 10.1038/onc.2008.168

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  98 in total

1.  Hdac3 is essential for the maintenance of chromatin structure and genome stability.

Authors:  Srividya Bhaskara; Sarah K Knutson; Guochun Jiang; Mahesh B Chandrasekharan; Andrew J Wilson; Siyuan Zheng; Ashwini Yenamandra; Kimberly Locke; Jia-Ling Yuan; Alyssa R Bonine-Summers; Christina E Wells; Jonathan F Kaiser; M Kay Washington; Zhongming Zhao; Florence F Wagner; Zu-Wen Sun; Fen Xia; Edward B Holson; Dineo Khabele; Scott W Hiebert
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

2.  Increased expression of SOX4 is associated with colorectal cancer progression.

Authors:  Baochun Wang; Yixiong Li; Fengbo Tan; Zhanxiang Xiao
Journal:  Tumour Biol       Date:  2016-01-14

Review 3.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

4.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer.

Authors:  Kim J Png; Mitsukuni Yoshida; Xiang H-F Zhang; Weiping Shu; Hyeseung Lee; Andreas Rimner; Timothy A Chan; Elizabeth Comen; Viktor P Andrade; Seok Won Kim; Tari A King; Clifford A Hudis; Larry Norton; James Hicks; Joan Massagué; Sohail F Tavazoie
Journal:  Genes Dev       Date:  2011-02-01       Impact factor: 11.361

5.  Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates.

Authors:  Jeremy A Miller; Jason Nathanson; Daniel Franjic; Sungbo Shim; Rachel A Dalley; Sheila Shapouri; Kimberly A Smith; Susan M Sunkin; Amy Bernard; Jeffrey L Bennett; Chang-Kyu Lee; Michael J Hawrylycz; Allan R Jones; David G Amaral; Nenad Šestan; Fred H Gage; Ed S Lein
Journal:  Development       Date:  2013-10-23       Impact factor: 6.868

6.  SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.

Authors:  Weijie Gu; Beihe Wang; Fangning Wan; Junlong Wu; Xiaolin Lu; Hongkai Wang; Yao Zhu; Hailiang Zhang; Guohai Shi; Bo Dai; Dingwei Ye
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

7.  Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells.

Authors:  Christopher D Scharer; Colleen D McCabe; Mohamed Ali-Seyed; Michael F Berger; Martha L Bulyk; Carlos S Moreno
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

8.  Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection.

Authors:  Ting-Jung Wu; Shih-Shin Chang; Chia-Wei Li; Yi-Hsin Hsu; Tse-Ching Chen; Wei-Chen Lee; Chau-Ting Yeh; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2015-12-11       Impact factor: 12.531

9.  Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.

Authors:  Dilek Colak; Muhammad A Chishti; Al-Bandary Al-Bakheet; Ahmed Al-Qahtani; Mohamed M Shoukri; Malcolm H Goyns; Pinar T Ozand; John Quackenbush; Ben H Park; Namik Kaya
Journal:  Mol Cancer       Date:  2010-06-12       Impact factor: 27.401

10.  JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma.

Authors:  Qingshan Chang; Jianguo Chen; Kevin J Beezhold; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Mol Cancer       Date:  2009-08-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.